Fragile X syndrome without CCG amplification has an FMR1 deletion
Ági K. Gedeon(Women's and Children's Hospital), John C. Mulley(The University of Adelaide), Antonella Manca(Azienda Ospedaliero Universitaria di Sassari), Bernhard Korn(German Cancer Research Center), Harriet L. Robinson(GeoVax (United States)), Emma K. Baker(The University of Melbourne), G.R. Sutherland(Women's and Children's Hospital), Bella Gross(German Cancer Research Center), S. Yu(Women's and Children's Hospital), Annemarie Poustka(German Cancer Research Center), M. W. Partington(University of King's College)
Cited by 219
Related Papers
Further segregation analysis of the fragile X syndrome with special reference to transmitting males
|Human Genetics|1985|512
PAK3 mutation in nonsyndromic X-linked mental retardation
|Nature Genetics|1998|472
<i>BRAF/NRAS</i> Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
|Journal of Clinical Oncology|2012|460
Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy
|Nature Genetics|2002|437